-
REGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Regeneron Pharmaceuticals (REGN)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.01 bn | 2.01 bn | 2.01 bn | 2.01 bn | 2.01 bn | 2.01 bn |
Cash burn (monthly) | (no burn) | 12.37 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 50.70 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 1.96 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 158.6 | n/a | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 1356 |
Opened positions | 136 |
Closed positions | 85 |
Increased positions | 525 |
Reduced positions | 451 |
13F shares | Current |
---|---|
Total value | 90.74 tn |
Total shares | 92.73 mm |
Total puts | 1.50 mm |
Total calls | 1.22 mm |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
FMR | 10.36 mm | $10.89 tn |
Vanguard | 9.32 mm | $9.80 tn |
BlackRock | 8.48 mm | $8.91 tn |
JPM JPMorgan Chase & Co. | 7.49 mm | $7.87 tn |
STT State Street | 4.90 mm | $5.15 tn |
Capital World Investors | 4.30 mm | $4.52 tn |
Capital International Investors | 3.35 mm | $3.52 tn |
Dodge & Cox | 2.31 mm | $2.43 tn |
Geode Capital Management | 2.27 mm | $2.38 tn |
BEN Franklin Resources | 1.90 mm | $1.91 tn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Bassler Bonnie L | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 1,548 |
2 Jan 25 | Bassler Bonnie L | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Kathryn Guarini | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 448 |
2 Jan 25 | Kathryn Guarini | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Goldstein Joseph L | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 6,548 |
2 Jan 25 | Goldstein Joseph L | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Zoghbi Huda Y | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 1,548 |
2 Jan 25 | Zoghbi Huda Y | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
2 Jan 25 | Ryan Arthur F | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 17,748 |
2 Jan 25 | Ryan Arthur F | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |